Skip to main content
AmigoFish

Semaglutide vs. Tirzepatide: Are We Closing the Gap?

From Docs Who Lift · · 41 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

How the STEP-UP trial came to life, and what made the 7.2mg dose possible

What the data actually says about weight loss and side effects at higher doses

Why trial design, pharmacokinetics, and estimands matter more than you think

What’s coming next in obesity meds: duals, triples, and even antagonists

The real talk on intermittent fasting, access issues, and preaching vs. science

Sign up for Dr. Spencer''s Clinic

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.

Back to Docs Who Lift · Report a problem